Role of MRI Assessment in Fertility Sparing Treatment for Cervical Cancer at Staging and Follow-up and for Identification of Risk Factors for Aggressive Disease.

Inclusion Criteria: * Patients with cervical cancer FIGO stage up to IB2-IIA1 (T size \< 4 cm) wishing to preserve fertility treated at the Oncological Gynecology Unit of Foundation Policlinico Universitario Agostino Gemelli. * absence of nodal disease, * no menopausal status * wish to preserve fertility * refusal of radical treatment. * Patients who had a pre-treatment and post-treatment magnetic resonance imaging. * Availability of digital MR images and histopathological samples. Exclusion Criteria: * Patients aged under 18 years. * Neuroendocrine cervical tumours or other rare histology, such as glassy cells or clear cell carcinoma non-HPV related adenocarcinoma. * ongoing pregnancy at the time of diagnosis. * Patients without available MR images on digital media or with low quality images.